Related Experiment Video
Updated: Jun 23, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Osteoporosis in china
1Center for Human Nutrition, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA. ywang@jhsph.edu
Summary:
Based on related studies published between 1980 and May 2008, we examine the prevalence of osteoporoses in mainland China, Hong Kong, and Taiwan. Overall, the prevalence of osteoporosis among these Chinese populations remains low compared to other Caucasian populations; in the mainland, it was approximately 13%.
Introduction:
Osteoporosis is a significant public health problem and has received great attention in industrialized countries. However, limited is known in many developing countries including China, where aging and changing lifestyles likely contribute to increased osteoporosis. The objectives of the study is to examine the disease burden (prevalence) and time trends of osteoporosis in mainland China, Hong Kong, and Taiwan.
Methods:
Related studies published in English and Chinese between January 1980 and May 2008 were reviewed and analyzed.
Results:
The prevalence increased with age and varied dramatically based on local versus international diagnosis criteria. In the mainland, reported overall prevalence of osteoporosis based on nationwide surveys ranged from 6.6% to 19.3% (average = 13.0%). The prevalence varied considerably across studies, and by regions, gender, and bone sites, but the urban to rural difference was small. In Hong Kong, the prevalence among women > or =50 years ranged from 34.1-37% in the spine; was 7% in the same aged men. In Taiwan, among those aged > or =50 years, average prevalence of osteoporosis was 11.4% in women and 1.6% in men.
Conclusions:
Future national programs need to monitor the burden of osteoporosis in China though available data indicate that the prevalence of osteoporosis remains low compared to that of other Caucasian populations.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...